Hot Stocks
|
Walgreens Boots Alliance… ShowHide Related Items >><< WBA Walgreens Boots Alliance - 06/01/23
- Walgreens, Vitamin Angels expand prenatal pilot program to nearly 400 stores
- 05/17/23
- San Francisco City announces $230M opioid settlement with Walgreens
- 05/12/23
- AmerisourceBergen announces common share repurchase from Walgreens Boots Alliance
- 05/12/23
- Walgreens Boots Alliance sells shares of AmerisourceBergen for $694M
- 06/05/23
- Amedisys announces receipt of unsolicited proposal from Optum
- 06/05/23
- Option Care Health issues statement on proposed merger with Amedisys
- 06/05/23
- Amedisys announces receipt of unsolicited proposal from Optum
- 06/05/23
- Amedisys announces receipt of unsolicited proposal from Optum
WBA Walgreens Boots Alliance - 20:34 Today
- Walgreens Boots sells remaining shares of Option Care Health for $330M
- 03/30/23 Deutsche Bank
- Walgreens Boots Alliance price target lowered to $46 from $47 at Deutsche Bank
- 03/29/23 UBS
- Walgreens Boots Alliance price target lowered to $37 from $39 at UBS
- 03/29/23 Truist
- Walgreens Boots Alliance price target lowered to $40 from $42 at Truist
- 20:34 Today
- Walgreens Boots sells remaining shares of Option Care Health for $330M
- 06/07/23 Truist
- Truist downgrades Amedisys on balanced risk/reward after rally
- 06/06/23 Credit Suisse
- Amedisys downgraded to Neutral from Outperform at Credit Suisse
- 05/08/23 TD Cowen
- Amedisys price target lowered to $84 from $95 at TD Cowen
WBA Walgreens Boots Alliance - 03/28/23
- Walgreens Boots reaffirms FY23 adjusted EPS view $4.45-$4.65, consensus $4.51
- 03/28/23
- Walgreens Boots Alliance reports Q2 adjusted EPS $1.16, consensus $1.10
- 03/27/23
- Notable companies reporting before tomorrow's open
- 03/27/23
- Notable companies reporting before tomorrow's open
- 05/03/23
- Option Care Health backs FY23 revenue view $4.15B-$4.375B, consensus $4.28B
- 05/03/23
- Option Care Health reports Q1 EPS 22c, consensus 18c
- 02/23/23
- Option Care Health sees 2023 revenue $4.15B-$4.375B, consensus $4.29B
- 02/23/23
- Option Care Health reports Q4 EPS 26c, consensus 22c
|
Recommendations
|
Walgreens Boots Alliance… ShowHide Related Items >><< WBA Walgreens Boots Alliance - 06/01/23
- Walgreens, Vitamin Angels expand prenatal pilot program to nearly 400 stores
- 05/17/23
- San Francisco City announces $230M opioid settlement with Walgreens
- 05/12/23
- AmerisourceBergen announces common share repurchase from Walgreens Boots Alliance
- 05/12/23
- Walgreens Boots Alliance sells shares of AmerisourceBergen for $694M
- 06/05/23
- Amedisys announces receipt of unsolicited proposal from Optum
- 06/05/23
- Option Care Health issues statement on proposed merger with Amedisys
- 06/05/23
- Amedisys announces receipt of unsolicited proposal from Optum
- 06/05/23
- Amedisys announces receipt of unsolicited proposal from Optum
WBA Walgreens Boots Alliance - 03/30/23 Deutsche Bank
- Walgreens Boots Alliance price target lowered to $46 from $47 at Deutsche Bank
- 03/29/23 UBS
- Walgreens Boots Alliance price target lowered to $37 from $39 at UBS
- 03/29/23 Truist
- Walgreens Boots Alliance price target lowered to $40 from $42 at Truist
- 03/26/23 Barclays
- Walgreens Boots Alliance price target lowered to $43 from $45 at Barclays
- 06/07/23 Truist
- Truist downgrades Amedisys on balanced risk/reward after rally
- 06/06/23 Credit Suisse
- Amedisys downgraded to Neutral from Outperform at Credit Suisse
- 05/08/23 TD Cowen
- Amedisys price target lowered to $84 from $95 at TD Cowen
- 05/05/23 Deutsche Bank
- Option Care Health price target lowered to $32.50 from $39 at Deutsche Bank
WBA Walgreens Boots Alliance - 03/28/23
- Walgreens Boots reaffirms FY23 adjusted EPS view $4.45-$4.65, consensus $4.51
- 03/28/23
- Walgreens Boots Alliance reports Q2 adjusted EPS $1.16, consensus $1.10
- 03/27/23
- Notable companies reporting before tomorrow's open
- 03/27/23
- Notable companies reporting before tomorrow's open
- 05/03/23
- Option Care Health backs FY23 revenue view $4.15B-$4.375B, consensus $4.28B
- 05/03/23
- Option Care Health reports Q1 EPS 22c, consensus 18c
- 02/23/23
- Option Care Health sees 2023 revenue $4.15B-$4.375B, consensus $4.29B
- 02/23/23
- Option Care Health reports Q4 EPS 26c, consensus 22c
|
Upgrade
|
China Renaissance analyst… ShowHide Related Items >><< - 01/13/23
- Trip.com Group sees surge in mainland China travel bookings
- 12/27/22
- China stocks rising with borders set to reopen on January 8
- 12/23/22
- PCAOB chair 'applauds' Congressional action to shorten HFCAA timeline
- 10:59 Today Daiwa
- Trip.com Group upgraded to Buy at Daiwa on stronger than expected demand
- 10:39 Today Daiwa
- Trip.com Group upgraded to Buy from Outperform at Daiwa
- 06:40 Today Barclays
- Trip.com Group price target raised to $49 from $46 at Barclays
- 06:36 Today Mizuho
- Trip.com Group price target raised to $50 from $49 at Mizuho
- 06/07/23
- Trip.com Group reports Q1 adjusted EPS 45c, consensus 25c
- 03/06/23
- Trip.com Group reports Q4 adjusted EPS 11c, consensus (3c)
- 03/06/23
- Notable companies reporting after market close
- 12/22/22
- China seen cutting quarantine for inbound overseas travelers, Global Times says
- 08:46 Today
- Fly Intel: Pre-market Movers
- 03/07/23
- What You Missed On Wall Street On Tuesday
- 03/07/23
- What You Missed On Wall Street This Morning
- 01/11/23
- #SocialStocks: Meta implements new restrictions for advertising to teens
- 06/07/23
- Trip.com options imply 6.0% move in share price post-earnings
- 03/06/23
- Trip.com options imply 5.9% move in share price post-earnings
- 12/14/22
- Trip.com call volume above normal and directionally bullish
|
Initiation
| ShowHide Related Items >><< - 11:20 Today
- Loop Media announces strategic partnership with Pypestream
- 05/23/23
- Loop Media set to join Russell 3000, 2000 and Microcap indexes June 26
- 03/09/23
- Loop Media enters partnership with St. Louis Bar & Grill in Canada
- 10/17/22 Roth Capital
- Loop Media initiated with a Buy at Roth Capital
|
Hot Stocks
| ShowHide Related Items >><< - 06/06/23
- Cathie Wood's ARK Investment sold 170K shares of DraftKings today
- 05/31/23
- Nevada reports April statewide gaming win up 2.77% to $1.16B
- 04/26/23
- Cathie Wood's ARK Investment sold 210K shares of DraftKings today
- 04/25/23
- Nevada reports March statewide gaming win down 3.18% to $1.31B
- 06/05/23 BTIG
- DraftKings price target raised to $31 from $27 at BTIG
- 06/05/23 JMP Securities
- DraftKings price target raised to $31 from $29 at JMP Securities
- 06/05/23 Jefferies
- DraftKings price target raised to $35 from $33 at Jefferies
- 05/25/23 Lake Street
- Lake Street starts Genius Sports with a Buy, $7 price target
- 05/04/23
- DraftKings raises FY23 revenue view to $3.14B-$3.24B from $2.85B-$3.05B
- 05/04/23
- DraftKings reports Q1 adjusted EPS (51c), consensus (89c)
- 05/04/23
- Notable companies reporting after market close
- 02/16/23
- DraftKings raises FY23 revenue view to $2.85B-$3.05B from $2.8B-$3B
- 05/18/23
- Teen charged with hacking DraftKings, bragged 'fraud is fun,' CNBC says
- 04/27/23
- DraftKings to launch free, ad-supported video streaming service, Bloomberg says
- 02/01/23
- DraftKings confirms laying off around 140 employees, iGaming NEXT reports
- 01/27/23
- Molson Coors to team up with DraftKings for Super Bowl commercial buzz, WSJ says
- 06/02/23
- Bet On It: Online sports betting bill okayed by Senate in North Carolina
- 05/26/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 05/22/23
- What You Missed On Wall Street On Monday
- 05/22/23
- What You Missed On Wall Street This Morning
- 05/04/23
- DraftKings options imply 7.9% move in share price post-earnings
- 02/24/23
- DraftKings put volume heavy and directionally bearish
- 02/21/23
- Unusually active option classes on open February 21st
- 02/16/23
- DraftKings options imply 8.1% move in share price post-earnings
|
Hot Stocks
| ShowHide Related Items >><< - 06/07/23
- Cathie Wood's ARK Investment bought 227.4K shares of Block today
- 06/01/23
- CFPB finds billions of dollars stored on payment apps lack may federal insurance
- 06/01/23
- CFPB finds billions of dollars stored on payment apps lack may federal insurance
- 05/04/23
- Block reports 30M monthly Cash App Card actives in March, up 34% y/y
- 06/05/23 Wolfe Research
- Block price target lowered to $85 from $90 at Wolfe Research
- 06/01/23 BofA
- Marqeta initiated with a Neutral at BofA
- 05/31/23 Mizuho
- Block point-of-sale business concerns may be overdone, says Mizuho
- 05/23/23 Baird
- Block reports GPV trends improved in May, says Baird
- 05/21/23
- Fly Intel: Top five weekend stock stories
- 05/04/23
- Block sees FY23 adjusted EBITEA at $1.36B vs. previous view of $1.3B
- 05/04/23
- Block reports Q1 EPS 40c, consensus 34c
- 05/04/23
- Notable companies reporting after market close
- 05/21/23
- Fintech should be scared as Apple reaches deeper into pockets, Barron's says
- 03/31/23
- Hindenburg says Block confirmed user accounts 'inflated'
- 03/31/23
- Hindenburg says Block confirmed 'inflated' user counts, ignored other issues
- 03/23/23
- Hindenburg short Block, accuses of facilitating 'fraud against consumers'
- 05/12/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 05/11/23
- What You Missed On Wall Street On Thursday
- 05/11/23
- What You Missed On Wall Street This Morning
- 05/11/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/24/23
- Square call volume above normal and directionally bullish
- 03/24/23
- Unusually active option classes on open March 24th
- 03/24/23
- Notable open interest changes for March 24th
- 03/17/23
- Square call volume above normal and directionally bullish
|
Hot Stocks
| ShowHide Related Items >><< VRTX Vertex Pharmaceuticals - 05/03/23
- Vertex announces FDA approval for KALYDECO to treat eligible infants with CF
- 04/26/23
- Vertex announces U.S. FDA approval for expanded use of Trikafta
- 04/25/23
- Stablix, Vertex collaborate for targeted protein stabilization therapeutics
- 04/10/23
- Sana Biotechnology CMO Sunil Agarwal to leave, Gary Meininger to succeed
- 06/01/23
- Crispr Therapeutics CEO Kulkarni sells $1.6M in company shares
- 04/27/23
- Crispr Therapeutics CEO Kulkarni sells $1.3M in company shares
- 04/03/23
- Vertex Pharmaceuticals, Crispr Therapeutics complete rolling BLAs to FDA
- 03/29/23
- Crispr Therapeutics announces departure of board member
VRTX Vertex Pharmaceuticals - 08:38 Today RBC Capital
- Vertex Pharmaceuticals price target raised to $323 from $315 at RBC Capital
- 05/30/23 William Blair
- William Blair starts Vertex with Outperform, $382 fair value estimate
- 05/30/23 William Blair
- Vertex Pharmaceuticals initiated with an Outperform at William Blair
- 05/25/23 WestPark Capital
- Vertex Pharmaceuticals initiated with a Hold at WestPark Capital
- 06/01/23 Barclays
- Crispr Therapeutics price target raised to $64 from $61 at Barclays
- 05/30/23 William Blair
- Crispr Therapeutics resumed with an Outperform at William Blair
- 05/23/23 Citi
- Crispr Therapeutics price target raised to $70 from $55 at Citi
- 05/09/23 Stifel
- Crispr Therapeutics price target lowered to $64 from $69 at Stifel
VRTX Vertex Pharmaceuticals - 05/01/23
- Vertex Pharmaceuticals backs FY23 revenue view of $9.55B-$9.7B, consensus $9.71B
- 05/01/23
- Vertex Pharmaceuticals reports Q1 EPS $2.69, consensus $3.00
- 02/07/23
- Vertex Pharmaceuticals guides FY23 revenue $9.55B-$9.70B, consensus $9.6B
- 02/07/23
- Vertex Pharmaceuticals reports Q4 EPS $3.76, consensus $3.51
- 05/08/23
- Crispr Therapeutics reports Q1 EPS (67c), consensus ($1.70)
- 02/22/23
- Crispr Therapeutics reports Q4 EPS ($1.41) vs. ($1.84) y/y
VRTX Vertex Pharmaceuticals - 02/07/23
- Vertex keeps cystic fibrosis drug out of developing countries, NY Times reports
VRTX Vertex Pharmaceuticals - 05/30/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/04/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/01/23
- Fly Intel: After-Hours Movers
- 03/21/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 04/13/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 04/13/23
- Fly Intel: Pre-market Movers
VRTX Vertex Pharmaceuticals - 05/01/23
- Vertex options imply 3.8% move in share price post-earnings
- 02/07/23
- Vertex options imply 3.7% move in share price post-earnings
- 06/07/23
- Crispr Therapeutics put volume heavy and directionally bearish
- 06/02/23
- Crispr Therapeutics put volume heavy and directionally bearish
- 05/26/23
- Crispr Therapeutics put volume heavy and directionally bearish
- 05/11/23
- Crispr Therapeutics put volume heavy and directionally bearish
|
Hot Stocks
| ShowHide Related Items >><< - 05/25/23
- Royal Gold COO Isto to retire
- 02/15/23
- Royal Gold sees Q1 stream segment sales 54K-59K GEOs
- 01/10/23
- Royal Gold provides update on Q4 2022 stream segment sales
- 01/05/23
- Royal Gold acquires more royalty interests on Cortez complex for $204.1M
- 15:45 Today
- Newmont Mining trading resumes
- 15:34 Today
- Newmont suspends work at Penasquito mine in Mexico, refutes labor union claims
- 14:34 Today
- Newmont Mining trading halted, news pending
- 05/19/23
- Newmont appoints Karyn Ovelmen as CFO
- 06/05/23 BofA
- Royal Gold downgraded to Underperform at BofA on operational concerns
- 06/05/23 BofA
- Royal Gold downgraded to Underperform from Neutral at BofA
- 04/21/23 Barclays
- Royal Gold price target raised to $122 from $119 at Barclays
- 04/20/23 Cantor Fitzgerald
- Royal Gold downgraded to Hold from Buy at Cantor Fitzgerald
- 05/25/23 Veritas
- Newmont upgraded to Reduce from Sell at Veritas
- 05/02/23 National Bank
- Newmont price target raised to C$94 from C$91 at National Bank
- 04/21/23 Barclays
- Newmont price target raised to $62 from $57 at Barclays
- 04/18/23 National Bank
- Newmont price target raised to C$91 from C$86 at National Bank
- 05/03/23
- Royal Gold reports Q1 adjusted EPS 96c, consensus 99c
- 02/15/23
- Royal Gold reports Q4 adjusted EPS 91c, consensus 81c
- 04/27/23
- Newmont reports Q1 EPS 40c, consensus 43c
- 02/23/23
- Newmont: Sustaining capital seen at $1-$1.2B per year over 5 year period
- 02/23/23
- Newmont reports Q4 EPS 44c, consensus 46c
- 03/18/23
- Newmont stock still worth buying as gold shines again, Barron's says
- 03/13/23
- Newmont, Newcrest agree to terms on NDA to allow for talks, AFR reports
- 06/05/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/12/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/15/23
- What You Missed On Wall Street On Monday
- 05/15/23
- What You Missed On Wall Street This Morning
- 04/11/23
- What You Missed On Wall Street On Tuesday
- 04/11/23
- What You Missed On Wall Street This Morning
- 04/21/23
- Royal Gold put buyer realizes 27% same-day gains
- 05/19/23
- Largest borrow rate increases among liquid names
- 05/04/23
- Newmont Mining call volume above normal and directionally bullish
- 05/02/23
- Newmont Mining call volume above normal and directionally bullish
- 04/04/23
- Newmont Mining call volume above normal and directionally bullish
|
Hot Stocks
| ShowHide Related Items >><< - 08:03 Today
- Univar expands ingredient porfolio with Grace's Syloid FP in Europe
- 06/06/23
- Univar stockholders approve pending acquisition by Apollo funds
- 06/05/23
- Univar names Alexandra Colin as General Counsel
- 05/09/23
- Univar signs distribution agreement in Brazil for sun care filters
- 06/07/23
- Apollo reports ATLAS SP, ABF Franchise receives commitments from ADIA
- 06/06/23
- Univar stockholders approve pending acquisition by Apollo funds
- 06/06/23
- Mosaicx announces launch of Mosaicx Agent program
- 06/05/23
- Apollo Funds to invest $2B in preferred equity of AT&T Mobility II
- 03/17/23 Fermium Research
- Univar downgraded to Hold from Buy at Fermium Research
- 03/14/23 Barclays
- Univar price target raised to $36 from $33 at Barclays
- 03/14/23 Vertical Research
- Univar downgraded to Hold from Buy at Vertical Research
- 02/23/23 Deutsche Bank
- Univar price target raised to $40 from $32 at Deutsche Bank
- 05/18/23 Citi
- Citi starts nine asset managers with seven Buy ratings
- 05/18/23 Citi
- Apollo Global initiated with a Buy at Citi
- 05/15/23 Barclays
- Apollo Global price target raised to $79 from $74 at Barclays
- 04/18/23 Keefe Bruyette
- Brookfield Asset Management downgraded to Underperform at Keefe Bruyette
- 05/08/23
- Univar reports Q1 adjusted EPS 63c, consensus 61c
- 02/21/23
- Univar sees Q1 adjusted EBITDA $200M-$220M
- 02/21/23
- Univar reports Q4 adjusted EPS 47c, consensus 54c
- 05/09/23
- Apollo Global reports Q1 adjusted EPS $1.42, consensus $1.47
- 05/08/23
- Notable companies reporting before tomorrow's open
- 05/08/23
- Notable companies reporting before tomorrow's open
- 02/09/23
- Apollo Global reports Q4 adjusted EPS $1.42, consensus $1.50
- 03/14/23
- Apollo Global agrees to buy Univar for $8.1B including debt, WSJ reports
- 02/18/23
- Dow, Celanese among stocks to play future of plastic, Barron's says
- 01/11/23
- Univar draws interest from Apollo, Platinum Equity, Bloomberg says
- 05/08/23
- Apollo participates in bid to acquire crypto lender Celsius, CoinDesk says
- 05/05/23
- Adnoc, Apollo to offer up to BRL 37.5B for Braskem, Folha says
- 05/04/23
- Applus drawing takeover interest from Apollo, others, Reuters says
- 05/04/23
- Apollo-led group nears deal to buy Arconic for $3B, WSJ reports
- 03/14/23
- What You Missed On Wall Street On Tuesday
- 03/14/23
- What You Missed On Wall Street This Morning
- 03/14/23
- Fly Intel: Pre-market Movers
- 01/03/23
- What You Missed On Wall Street On Tuesday
- 05/21/23
- Opening Day: Monogram Orthopaedics stock soars in trading debut
- 05/19/23
- What You Missed On Wall Street On Friday
- 05/19/23
- What You Missed On Wall Street This Morning
- 05/19/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 04/05/23
- Apollo Global put volume heavy and directionally bearish
- 01/09/23
- Apollo Global put volume heavy and directionally bearish
- 12/28/22
- Apollo Global put volume heavy and directionally bearish
- 12/22/22
- Apollo Global put volume heavy and directionally bearish
|
On The Fly
|
Check out this evening's… ShowHide Related Items >><< - $234.83 /
+10.24 (+4.56%) - 16:41 Today
- General Motors says customers able to use Tesla super chargers by next spring
- 16:32 Today
- General Motors to adopt Tesla charging standard for next-gen EVs in 2025
- 16:06 Today
- GM CEO says will discuss 'future of EV charging' in event with Tesla CEO
- 06/05/23
- Tesla 'happy' to license Autopilot/FSD or other Tesla technology, says Elon Musk
- 16:08 Today
- Planet Labs reports Q1 customer count up 9% from last year
- 05/25/23
- Planet Labs announces partnership with United Arab Emirates Space Agency
- 04/06/23
- Planet Labs rises 11.9%
- 04/06/23
- Planet Labs rises 12.3%
ODC Oil-Dri Corporation of America - 16:42 Today
- Oil-Dri Corporation of America raises quarterly dividend by 4%
- 05/23/23
- Duckhorn Portfolio names Jennifer Fall Jung CFO
- 05/04/23
- Duckhorn Portfolio to acquire North Coast Winery and Vineyards for $55M
- 16:09 Today
- Vail Resorts lowers FY23 net income view to $251M-$283M from $321M-$396M
- 04/21/23
- Vail Resorts reports ski season-to-date visits up 6.1% y-o-y
- 03/09/23
- Vail Resorts lowers FY23 net income view to $282M-$328M from $321M-$396M
- 03/09/23
- Vail Resorts raises dividend 8%, increases share buyback authorization by 2.5M
- 13:13 Today
- General Motors to invest $500M-plus in Arlington Assembly for future SUVs
- 16:00 Today
- Expensify to join Russell 3000 index
- 06/05/23
- Expensify CEO sells $1.31M in common stock
- 04/11/23
- Expensify: Employees purchased 147K shares of company stock via SPMP in quarter
- 04/11/23
- Expensify says FY23 total dollar amount in reducing share count $629K to date
- 16:13 Today
- DocuSign jumps 13% to $66.21 after Q1 results beat, FY24 revenue view raised
- 16:08 Today
- DocuSign reports Q1 billings $674.8M, up 10% y/y
- 05/16/23
- DocuSign names Blake Grayson as incoming CFO
- 03/09/23
- DocuSign CFO Cynthia Gaylor to step down later this year
- 06/02/23
- S&P DJI announces changes to S&P400 at open on 6/20
- 04/18/23
- Comtech names Nicole Robinson chief strategy officer
- 04/17/23
- Comtech secures contracts for hybrid designed high-speed SATCOM solutions
- 04/12/23
- Comtech names Donald Walther as CLO
- 16:13 Today
- Braze jumps 11% to $37.74 after Q1 earnings beat and guidance raise
- 04/04/23
- Rackspace Technology, Braze enter multi-year agreement
- 03/30/23
- Braze to acquire North Star
- 12/13/22
- Braze falls 6% to $27.16 after Q3 results and guidance
- 12/14/22
- Argan increases share buyback program to $125M from $100M
ODC Oil-Dri Corporation of America - 06/07/23 Canaccord
- Braze earnings report not expecting any major surprises, says Canaccord
- 05/18/23 Scotiabank
- Scotiabank starts Braze at Sector Perform, says 'can weather the storm'
- 05/17/23 Scotiabank
- Braze initiated with a Sector Perform at Scotiabank
- 05/10/23 Wells Fargo
- Braze initiated with an Overweight at Wells Fargo
- 06/06/23 RBC Capital
- Duckhorn Portfolio facing deteriorating category dynamics, says RBC Capital
- 06/05/23 JPMorgan
- Duckhorn Portfolio price target lowered to $17 from $18 at JPMorgan
- 03/09/23 Barclays
- Duckhorn Portfolio upgraded to Overweight at Barclays after pullback
- 03/09/23 Barclays
- Duckhorn Portfolio upgraded to Overweight from Equal Weight at Barclays
- 06/07/23 Jefferies
- DocuSign demand stable, but setup 'tough' into Q1, says Jefferies
- 06/07/23 Citi
- DocuSign price target lowered to $73 from $80 at Citi
- 05/31/23 UBS
- DocuSign price target lowered to $45 from $52 at UBS
- 03/10/23 BofA
- DocuSign price target lowered to $68 from $72 at BofA
- 05/10/23 Lake Street
- Expensify price target lowered to $10 from $11 at Lake Street
- 05/10/23 Piper Sandler
- Expensify price target lowered to $9 from $10 at Piper Sandler
- 05/10/23 Citi
- Expensify price target lowered to $10 from $12 at Citi
- 05/10/23 JMP Securities
- Expensify price target lowered to $12 from $15 at JMP Securities
- 05/02/23 JMP Securities
- Planet Labs initiated with an Outperform at JMP Securities
- 04/18/23 Citi
- Planet Labs initiated with a Buy at Citi
- 03/31/23 Deutsche Bank
- Planet Labs price target lowered to $6 from $7 at Deutsche Bank
- 03/30/23 Needham
- Planet Labs price target lowered to $8 from $9 at Needham
- 03/10/23 Barclays
- Argan price target raised to EUR 95 from EUR 87 at Barclays
- 09/23/22 Barclays
- Argan price target lowered to EUR 87 from EUR 104 at Barclays
- 10/04/22 Northland
- Comtech cloud messaging customer likely AT&T or T-Mobile, says Northland
- 06/15/22 Jefferies
- Comtech downgraded to Hold from Buy at Jefferies
- 06/13/22 Noble Capital
- Comtech upgraded to Outperform from Market Perform at Noble Capital
- 06/10/22 Citi
- Comtech price target lowered to $14 from $20 at Citi
- 03/30/23 Jefferies
- Vail Resorts price target raised to $245 from $232 at Jefferies
- 03/10/23 Truist
- Vail Resorts price target lowered to $262 from $292 at Truist
- 03/10/23 Deutsche Bank
- Vail Resorts price target lowered to $269 from $289 at Deutsche Bank
- 03/10/23 Stifel
- Vail Resorts price target lowered to $238 from $261 at Stifel
- $234.83 /
+10.24 (+4.56%) - 06/06/23 Piper Sandler
- Tesla not 'cheap' based on automotive business alone, says Piper Sandler
- 06/05/23 Barclays
- Tesla China deliveries stable to slightly positive, says Barclays
- 06/05/23 Citi
- Tesla price target raised to $215 from $175 at Citi
- 05/30/23 Roth MKM
- Ford access to Tesla charger network positive for entire space, says Roth MKM
- 09:13 Today Bernstein
- Lyft takeover cannot be ruled out, says Bernstein
- 06/05/23 Citi
- General Motors price target raised to $85 from $79 at Citi
- 05/01/23 Morgan Stanley
- Morgan Stanley upgrades 'oversold' General Motors to Overweight
- 05/01/23 Morgan Stanley
- General Motors upgraded to Overweight from Equal Weight at Morgan Stanley
- $234.83 /
+10.24 (+4.56%) - 04/19/23
- Tesla reports Q1 EPS 85c, consensus 85c
- 04/19/23
- Notable companies reporting after market close
- 03/02/23
- Aehr Test Systems reiterates annual guidance, comments on Tesla statements
- 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 16:07 Today
- Planet Labs reports Q1 EPS (13c), consensus (15c)
- 04/18/23
- CORRECTION: Planet Labs DID NOT see 2023 core FFO view $5.42-$5.50
- 04/18/23
- Planet Labs narrows 2023 core FFO view to $5.42-$5.50 from $5.40-$5.50
- 03/29/23
- Planet Labs sees FY24 revenue $248M-$268M, consensus $259.0M
ODC Oil-Dri Corporation of America - 16:20 Today
- Oil-Dri Corporation of America reports Q3 EPS $1.94 vs. 35c last year
- 16:08 Today
- Duckorn Portfolio raises FY23 EPS view to 64c-66c from 63c-65c, consensus 64c
- 16:07 Today
- Duckhorn Portfolio reports Q3 adjusted EPS 16c, consensus 12c
- 03/08/23
- Duckhorn Portfolio raises FY23 EPS view to 63c-65c from 62c-64c
- 03/08/23
- Duckhorn Portfolio reports Q2 adjusted EPS 18c, consensus 17c
- 16:08 Today
- Vail Resorts reports Q3 EPS $8.18, consensus $8.84
- 03/09/23
- Vail Resorts reports Q2 EPS $5.16, consensus $6.10
- 04/25/23
- General Motors raises FY23 adjusted EPS view to $6.35-$7.35 from $6.00-$7.00
- 04/25/23
- General Motors reports Q1 adjusted EPS $2.21, consensus $1.71
- 04/24/23
- Notable companies reporting before tomorrow's open
- 05/09/23
- Expensify reports Q1 EPS (7c), consensus 8c
- 16:07 Today
- DocuSign raises FY24 revenue view to $2.713B-$2.725B from $2.7B-$2.71B
- 16:06 Today
- DocuSign sees Q2 revenue $675M-$679M, consensus $670.37M
- 16:05 Today
- DocuSign reports Q1 adjusted EPS 72c, consensus 56c
- 13:17 Today
- Notable companies reporting after market close
- 16:18 Today
- Comtech sees Q4 revenue up 2%-4% sequentially
- 16:15 Today
- Comtech reports Q3 adjusted EBITDA $12.5M vs. $11.2M last year
- 03/09/23
- Comtech sees Q3 revenue up 1% to 3% from Q2
- 03/09/23
- Comtech reports Q2 EPS (23c), consensus (9c)
- 16:12 Today
- Braze raises FY24 EPS view to (55c) to (51c) from (59c) to (55c)
- 16:11 Today
- Braze sees Q2 EPS (14c) to (13c), consensus (16c)
- 16:10 Today
- Braze reports Q1 EPS (13c), consensus (18c)
- 03/30/23
- Braze sees FY24 EPS (59c) to (55c), consensus (57c)
- 16:06 Today
- Argan reports Q1 EPS 16c vs. 50c last year
- 04/12/23
- Argan reports Q4 EPS $1.00, two estimates 71c
|